# AMZ2

## Overview
AMZ2, or archaelysin family metallopeptidase 2, is a gene that encodes a metallopeptidase protein involved in proteolytic processes essential for cellular regulation and protein turnover. The AMZ2 protein functions by degrading peptide bonds, a process that requires metal ions for its enzymatic activity. This protein is categorized as a metallopeptidase and is crucial for the maturation and degradation of proteins, thereby maintaining cellular homeostasis and regulating signaling pathways. The protein's activity is vital for the removal of damaged or misfolded proteins, preventing the accumulation of toxic aggregates within cells. AMZ2's role in these processes influences cellular growth, differentiation, and response to environmental changes, highlighting its importance in maintaining cellular health and adaptability (Parker2016Molecular; Gabriel2015Role).

## Function
AMZ2 (archaelysin family metallopeptidase 2) is a gene encoding a protein that plays a significant role in proteolytic processes, which are essential for maintaining protein turnover and cellular regulation. As a metallopeptidase, AMZ2 requires metal ions to facilitate its enzymatic activity, primarily functioning in the degradation of peptide bonds. This activity is crucial for the maturation and degradation of proteins, thereby contributing to cellular homeostasis and the regulation of signaling pathways.

The protein encoded by AMZ2 is active in various cellular compartments, where it participates in the breakdown of proteins into peptides and amino acids. This process is vital for the removal of damaged or misfolded proteins, thus preventing the accumulation of potentially toxic protein aggregates within the cell. By regulating protein levels and quality, AMZ2 helps maintain the balance of cellular processes and supports the proper functioning of cellular signaling mechanisms.

Through its involvement in these molecular processes, AMZ2 influences several organismal outcomes, including the regulation of cellular growth, differentiation, and response to environmental changes. Its activity is integral to the dynamic regulation of the proteome, ensuring that cells can adapt to physiological demands and maintain overall cellular health.

## Clinical Significance
Mutations and alterations in the AMZ2 gene have been implicated in various diseases and conditions, although the clinical significance is not fully understood. In the context of lymphoproliferative disorders, AMZ2 is noted to have damaging missense mutations, such as T174K, in a patient's B-cell clone. However, these mutations do not fall within the predicted peptidase domain, and their specific functional consequences remain unclear (Parker2016Molecular).

In cancer research, AMZ2 has been identified as one of the genes affected by cisplatin treatment, which induces exon exclusion events, specifically the exclusion of exon 3. This splicing alteration is significant, with a p-value of 0.001, suggesting a potential role in the cellular response to chemotherapy (Gabriel2015Role).

AMZ2 has also been associated with sperm morphology defects, particularly vacuolated spermatozoa, indicating its involvement in reproductive health. However, detailed information on the clinical significance of these mutations is lacking (Graziani2024Genetic).

In the context of COVID-19, AMZ2 was identified as an upregulated gene in affected tissues, highlighting its potential as a biomarker for understanding the disease's pathogenesis (Aishwarya2020Computational). Further research is needed to elucidate the full clinical implications of AMZ2 mutations and expression alterations.

## Interactions



## References


[1. (Parker2016Molecular) Jeremy D.K. Parker, Yaoqing Shen, Erin Pleasance, Yvonne Li, Jacqueline E. Schein, Yongjun Zhao, Richard Moore, Joanna Wegrzyn-Woltosz, Kerry J. Savage, Andrew P. Weng, Randy D. Gascoyne, Steven Jones, Marco Marra, Janessa Laskin, and Aly Karsan. Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing. Molecular Case Studies, 2(2):a000679, March 2016. URL: http://dx.doi.org/10.1101/mcs.a000679, doi:10.1101/mcs.a000679. This article has 3 citations.](https://doi.org/10.1101/mcs.a000679)

[2. (Aishwarya2020Computational) S. Aishwarya, K. Gunasekaran, and A. Anita Margret. Computational gene expression profiling in the exploration of biomarkers, non-coding functional rnas and drug perturbagens for covid-19. Journal of Biomolecular Structure and Dynamics, 40(8):3681â€“3696, November 2020. URL: http://dx.doi.org/10.1080/07391102.2020.1850360, doi:10.1080/07391102.2020.1850360. This article has 10 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/07391102.2020.1850360)

[3. (Gabriel2015Role) Maude Gabriel, Yves Delforge, Adeline Deward, Yvette Habraken, Benoit Hennuy, Jacques Piette, Roscoe Klinck, Benoit Chabot, Alain Colige, and Charles Lambert. Role of the splicing factor srsf4 in cisplatin-induced modifications of pre-mrna splicing and apoptosis. BMC Cancer, April 2015. URL: http://dx.doi.org/10.1186/s12885-015-1259-0, doi:10.1186/s12885-015-1259-0. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12885-015-1259-0)

[4. (Graziani2024Genetic) Andrea Graziani, Maria Santa Rocca, Cinzia Vinanzi, Giulia Masi, Giuseppe Grande, Luca De Toni, and Alberto Ferlin. Genetic causes of qualitative sperm defects: a narrative review of clinical evidence. Genes, 15(5):600, May 2024. URL: http://dx.doi.org/10.3390/genes15050600, doi:10.3390/genes15050600. This article has 3 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/genes15050600)